We proudly offer cutting-edge, medically supervised weight loss programs, featuring advanced treatments like semaglutide and tirzepatide injections , as well as supportive therapies such as skinny shots and hormonal optimization
and reminders are provided to participants to ensure compliance with the trial dosing regimen
GLP-1 agonists affect diverse obesity etiopathogenic processes such as abnormal food intake regulation, adipocyte dysfunction, insulin resistance, adipokine production, inflammation, endothelial dysfunction, lipid metabolism, and oxidative stress
Clinical studies have demonstrated that sustained weight reductiontypically achieved through caloric restriction and increased physical activitycan lead to favourable changes in lipid parameters, including reductions in total cholesterol, low-density lipoprotein cholesterol (LDL-C), and triglycerides, alongside modest increases in high-density lipoprotein cholesterol (HDL-C)
Assessment may include: Comprehensive physician consultation Body composition analysis Personalized nutrition guidance Lifestyle coaching Follow-up monitoring Ongoing review of treatment response Depending on clinical assessment, eligible patients may discuss prescription options such as semaglutide or liraglutide alongside broader strategies for long-term weight management
